HORMONE RECEPTOR POSITIVE MALIGNANT NEOPLASM OF BREAST
Clinical trials for HORMONE RECEPTOR POSITIVE MALIGNANT NEOPLASM OF BREAST explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE MALIGNANT NEOPLASM OF BREAST trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE MALIGNANT NEOPLASM OF BREAST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in shrinking Hard-to-Treat breast tumors
Disease control CompletedThis study tested a new oral drug called BGB-43395 in 33 Chinese patients with advanced or metastatic HR+/HER2- breast cancer and other solid tumors. The drug blocks a protein (CDK4) that helps cancer cells grow. The goal was to find a safe dose and see if it can shrink tumors wh…
Matched conditions: HORMONE RECEPTOR POSITIVE MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo shows promise for advanced breast cancer
Disease control CompletedThis study tested a combination of two drugs, palbociclib and tamoxifen, as the first treatment for people with a certain type of advanced breast cancer (HR-positive, HER2-negative). The goal was to see how long the cancer could be kept from growing. 49 participants took both pil…
Matched conditions: HORMONE RECEPTOR POSITIVE MALIGNANT NEOPLASM OF BREAST
Phase: PHASE2 • Sponsor: Oana Danciu, MD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC